Figure 4 | Scientific Reports

Figure 4

From: Efficacy and biological safety of lopinavir/ritonavir based anti-retroviral therapy in HIV-1-infected patients: a meta-analysis of randomized controlled trials

Figure 4

Meta-analysis of the efficacy for pregnant women in terms of (a) preterm birth rate (heterogeneity: I2 = 51.7% and p = 0.043, publication bias: p = 0.536), (b) low birth weight rate (heterogeneity: I2 = 67.4% and p = 0.005, publication bias: p = 1.000) and (c) mother-to-child transmission rate of HIV (heterogeneity: I2 = 0% and p = 0.828, publication bias: p = 0.707).

Back to article page